- Presentations
- 2
- Markets
- 1
Imlygic is a brand of Talimogene laherparepvec marketed by Amgen, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Talimogene laherparepvec
- Brand owner
- Amgen
- Registered in
- United States
- Strengths and forms
- 1000000 PFU/mL injectable suspension, 100000000 PFU/mL injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Imlygic 1000000 PFU/mL injectable suspensionIntralesional Cold chain | Amgen | US FDA | Available on request |
| Imlygic 100000000 PFU/mL injectable suspensionIntralesional Cold chain | Amgen | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Imlygic
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.